Microfluidic Biopolymer Synthesis via Electrowetting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for DNA synthesis are limited in producing long strands, are not highly automatable, and lack efficient methods for archival storage and dynamic sequence modification of biopolymers.
Innovation Solution
The development of microfluidic systems using Electrowetting on Dielectric (EWOD) technology for the automated, template-free synthesis and modification of biopolymers, enabling the production of long nucleic acid strands and simultaneous synthesis of multiple sequences, with capabilities for encapsulation, barcoding, and dynamic sequence alteration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Length of moving object
If phosphoramidite chemical synthesis is used, then oligonucleotide synthesis can be achieved with controlled pore glass support, but the length of oligo is limited to up to only 200 nucleotides
Solution Approach 1:
The patent replaces traditional chemical phosphoramidite synthesis with enzymatic synthesis using terminal deoxynucleotidyl transferase (TdT) and telomerase. This biochemical substitution enables synthesis of extremely long DNA strands (thousands to millions of nucleotides) by leveraging natural enzymatic polymerization mechanisms rather than chemical bonding, thereby resolving the length limitation while maintaining synthesis reliability through enzymatic fidelity.
Solution Approach 2:
The patent fundamentally changes the synthesis parameters by switching from chemical reagents (phosphoramidites, tetrazole, iodine) to enzymatic reagents (TdT, telomerase, dNTPs). This parameter change enables continuous elongation of DNA strands beyond the 200-nucleotide limit by utilizing the enzyme's ability to repeatedly add nucleotides in a template-independent manner, achieving reliable synthesis of very long oligonucleotides.
2Productivity
If column-based phosphoramidite synthesis is used, then simultaneous synthesis of 96-768 oligonucleotides is feasible, but automation is limited
Solution Approach 1:
The patent implements automated liquid handling systems with robotic pipetting and microfluidic devices that autonomously perform droplet generation, nucleotide addition, and washing steps. The system uses computer-controlled mechanisms to automatically sequence-specifically add nucleotides to thousands of individual droplets containing TdT enzyme and initiators, eliminating manual intervention and achieving high-throughput automated synthesis of long oligonucleotides.
Solution Approach 2:
The patent employs microfluidic devices with integrated pumps and fluidic channels to automatically transport reagents, generate picoliter-scale droplets, and control the addition of nucleotides to each reaction compartment. This hydraulic automation enables precise, high-throughput delivery of reagents to thousands of parallel reactions, significantly increasing both productivity and automation level compared to manual column-based methods.
3Length of moving object
If traditional DNA synthesis methods are used, then sequencing is achieved, but synthesis of long strands greater than 200 bases is not feasible
Solution Approach 1:
The patent replaces infeasible chemical synthesis for long strands with feasible enzymatic synthesis using TdT and telomerase. These enzymes naturally polymerize DNA to extreme lengths by adding dNTPs to 3' ends of initiators in a template-independent manner, making the manufacture of long DNA strands (thousands to millions of bases) practically achievable where chemical methods fail.
Solution Approach 2:
The patent changes the fundamental synthesis parameters from chemical phosphoramidite coupling to enzymatic polymerization with TdT/telomerase. This parameter change enables continuous strand elongation beyond 200 bases by utilizing the enzyme's inherent ability to repeatedly catalyze nucleotide addition, thereby making long DNA strand manufacture feasible while maintaining ease of operation through standardized enzymatic protocols.
4Productivity
If manual biopolymer synthesis is used, then production is achieved, but scalability and parallelization are limited
Solution Approach 1:
The patent divides the synthesis system into thousands of independent micro-reactors or droplets, each containing TdT enzyme and a specific initiator sequence. This segmentation enables parallel synthesis of numerous different oligonucleotide sequences simultaneously in a single device, achieving high scalability and throughput while managing complexity through modular, addressable reaction compartments that can be independently controlled.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the scalable, automated synthesis of long biopolymers, facilitates archival storage, and allows for dynamic sequence modification and retrieval, enhancing the efficiency and automation of biopolymer production and storage processes.
Implementation Method 1
The development of microfluidic systems using Electrowetting on Dielectric (EWOD) technology for the automated, template-free synthesis and modification of biopolymers
Data Source
AI summary
Methods for the automated template-free synthesis of user-defined sequence controlled biopolymers using microfluidic devices are described. The methods facilitate simultaneous synthesis of up to thousands of uniquely addressed biopolymers from the controlled movement and combination of regents as fluid droplets using microfluidic and EWOD-based systems. In some forms, biopolymers including nucleic acids, peptides, carbohydrates, and lipids are synthesized from step-wise assembly of building blocks based on a user-defined sequence of droplet movements. In some forms, the methods synthesize uniquely addressed nucleic acids of up to 1,000 nucleotides in length. Methods for adding, removing and changing barcodes on biopolymers are also provided. Biopolymers synthesized according to the methods, and libraries and databases thereof are also described. Modified biopolymers, including chemically modified nucleotides and biopolymers conjugated to other molecules are described.